Management of Generalized Myasthenia Gravis in Pediatric Patients

Key Takeaways

• Diagnosing pediatric gMG is challenging due to its rarity and symptom overlap with other neuromuscular disorders, necessitating careful clinical evaluation.
• Standard management includes acetylcholinesterase inhibitors, corticosteroids, and immunosuppressants, customized to each patient's needs.
• Investigational agents, particularly monoclonal antibodies, are promising for enhancing treatment outcomes in pediatric gMG, indicating potential for personalized therapy advancements.